PINK
GCAN

Greater Cannabis Company Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Greater Cannabis Company Inc Stock Price

Vitals

Today's Low:
$0.001
Today's High:
$0.0013
Open Price:
$0.0012
52W Low:
$0.0003
52W High:
$0.0013
Prev. Close:
$0.001
Volume:
2863400

Company Statistics

Market Cap.:
$768639
Book Value:
-0.001
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$-5025
Profit Margin:
0%
Return on Assets TTM:
-37.63%
Return on Equity TTM:
0%

Company Profile

Greater Cannabis Company Inc had its IPO on under the ticker symbol GCAN.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Greater Cannabis Company Inc has a staff strength of 1 employees.

Stock update

Shares of Greater Cannabis Company Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a +20% increase from the previous day's closing price.

A total volume of 2,863,400 shares were traded at the close of the day’s session.

In the last one week, shares of Greater Cannabis Company Inc have increased by +20%.

Greater Cannabis Company Inc's Key Ratios

Greater Cannabis Company Inc has a market cap of $768639, indicating a price to book ratio of 0 and a price to sales ratio of 50.7019.

In the last 12-months Greater Cannabis Company Inc’s revenue was $0 with a gross profit of $-5025 and an EBITDA of $-167443. The EBITDA ratio measures Greater Cannabis Company Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Greater Cannabis Company Inc’s operating margin was 0% while its return on assets stood at -37.63% with a return of equity of 0%.

In Q2, Greater Cannabis Company Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 73.7%.

Greater Cannabis Company Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Greater Cannabis Company Inc’s profitability.

Greater Cannabis Company Inc stock is trading at a EV to sales ratio of 71.4646 and a EV to EBITDA ratio of -2.2188. Its price to sales ratio in the trailing 12-months stood at 50.7019.

Greater Cannabis Company Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$248664.00
Total Liabilities
$881605.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Greater Cannabis Company Inc ended 2024 with $248664.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $248664.00 while shareholder equity stood at $-632941.00.

Greater Cannabis Company Inc ended 2024 with $0 in deferred long-term liabilities, $881605.00 in other current liabilities, 732639.00 in common stock, $-4381013.00 in retained earnings and $0 in goodwill. Its cash balance stood at $240747.00 and cash and short-term investments were $240747.00. The company’s total short-term debt was $503,437 while long-term debt stood at $0.

Greater Cannabis Company Inc’s total current assets stands at $240747.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $5340.00 and inventory worth $0.

In 2024, Greater Cannabis Company Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Greater Cannabis Company Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0
52-Week High
$0.0013
52-Week Low
$0.0003
Analyst Target Price
$

Greater Cannabis Company Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.0013 and a 52-week low of $0.0013. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6073.9% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Greater Cannabis Company Inc

The stock symbol (also called stock or share ticker) of Greater Cannabis Company Inc is GCAN

The IPO of Greater Cannabis Company Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$34.6
0.01
+0.03%
$74.63
-3.62
-4.63%
$70.11
-3.64
-4.94%
$160.45
-6.9
-4.12%
$4.25
-0.05
-1.16%
$26
0.91
+3.63%
$1.17
0
0%
$16.13
0.13
+0.81%
$12.75
-0.3
-2.3%
Veracyte Inc (VCYT)
$25.3
0.01
+0.04%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland.

Address

15 Walker Avenue, Baltimore, MD, United States, 21208